Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment

@article{Fleisher2007ClinicalPO,
  title={Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment},
  author={A. Fleisher and B. Sowell and C. Taylor and A. Gamst and R. Petersen and L. Thal},
  journal={Neurology},
  year={2007},
  volume={68},
  pages={1588 - 1595}
}
  • A. Fleisher, B. Sowell, +3 authors L. Thal
  • Published 2007
  • Medicine
  • Neurology
  • Objective: To investigate the neurocognitive measures that best predict progression from amnestic mild cognitive impairment (aMCI) to Alzheimer disease (AD). Methods: We evaluated 539 participants with aMCI from the Alzheimer's Disease Cooperative Study clinical drug trial of donepezil, vitamin E, or placebo. During the study period of 36 months, 212 aMCI participants progressed to AD. Using progression from aMCI to AD within 36 months as the dependent variable, a generalized linear model was… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 60 REFERENCES
    A new rating scale for Alzheimer's disease.
    • 3,334